Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $2,011+, returning 11,202.4%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 11,202.4% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Diginex Limited Ordinary Shares (DGNX) | 2,553.52% |
DeFi Development (DFDV) | 2,179.68% |
WW International, Inc Common Stock (WW) | 2,005.34% |
Zepp Health (ZEPP) | 1,612.69% |
Abits (ABTS) | 1,215.05% |
FiEE (FIEE) | 1,147.71% |
Oncology Institute (TOI) | 1,056.86% |
Abivax SA American Depositary Shares (ABVX) | 1,044.2% |
Lizhi (SOGP) | 898.13% |
Global Interactive Technologies (GITS) | 879.25% |
Nova Lifestyle I (NVFY) | 689.71% |
Epsium Enterprise Limited Ordinary Shares (EPSM) | 683.48% |
M3-Brigade Acquisition V Corp Warrant (MBAVW) | 670.44% |
Dominari (DOMH) | 653.89% |
Airnet Technology (ANTE) | 627.88% |
Mobilicom Limited Warrants (MOBBW) | 625.27% |
Lixte Biotechnology (LIXTW) | 617.86% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 564.26% |
mF International Limited Ordinary Shares (MFI) | 547.18% |
ThredUp (TDUP) | 539.58% |
Eightco (OCTO) | 514.9% |
Forward Industries (FORD) | 497.75% |
Better Home & Finance (BETR) | 479.14% |
